Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy

BACKGROUND: Acquiring resistance to endocrine therapy is common in metastatic hormone-receptor-positive breast cancer (MBC). These patients most often transition either to next-line endocrine therapy or to systemic chemotherapy. However, withdrawal of endocrine therapy and observation as is selectiv...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Cancer
Huvudupphovsmän: Chavarri-Guerra, Y, Higgins, M J, Szymonifka, J, Cigler, T, Liedke, P, Partridge, A, Ligibel, J, Come, S E, Finkelstein, D, Ryan, P D, Goss, P E
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2014
Ämnen:
Clinical Study
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4260029/
https://ncbi.nlm.nih.gov/pubmed/25233398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.502
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk